Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest General anesthetics Stories

2013-04-24 08:29:26

CUPERTINO, Calif., April 24, 2013 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) first quarter 2013 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, May 2, 2013 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2013-04-24 08:29:02

- Patients in the 30 mcg sufentanil NanoTab treatment group experienced significantly greater reduction in pain as measured by SPID-12 vs. placebo - REDWOOD CITY, Calif., April 24, 2013 /PRNewswire/ --- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced top-line results demonstrating that a placebo-controlled,...

2013-04-12 12:13:31

Surgical patients who demonstrated heightened pain sensitivity, or hyperalgesia, induced by high doses of a synthetic opioid had their symptoms alleviated by co-treatment with dexmedetomidine, according to new research. Study investigators, who presented their results today at the 29th Annual Meeting of the American Academy of Pain Medicine, concluded that dexmedetomidine may be a new and effective treatment option for opioid-induced hyperalgesia (OIH). OIH refers to increased pain...

2013-03-27 23:03:47

On February 25th, 2013, Hospira announced the recall of three lots of Propofol Injectable Emulsion due to visible particles embedded in the glass. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Propofol side effects. http://www.attorneyone.com/propofol-recall/ San Diego, CA (PRWEB) March 27, 2013 AttorneyOne.com, a recognized authority on...

2013-03-27 23:02:40

According to a new market report published by Transparency Market Research "Medical Gases and Equipment Market (Pure Gases, Gas Mixtures, Oxygen, Nitrous Oxide, Carbon Dioxide-Oxygen, Nitrous Oxide-Oxygen, Manifolds, Vacuum Systems)- Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018," in 2011, the global medical gases and equipment market was calculated at USD 5.3 billion and is expected to grow at a CAGR of 8% from 2012 to 2018, to reach an estimated value of USD 9...

2013-03-20 08:25:45

NEW YORK, March 20, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Medical Gases and Equipment Market (Pure Gases, Gas Mixtures, Oxygen, Nitrous Oxide, Carbon Dioxide-Oxygen, Nitrous Oxide-Oxygen, Manifolds, Vacuum Systems)- Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018," in 2011, the global medical gases and equipment market was calculated at USD 5.3 billion...

Propofol Addiction On The Rise In Healthcare Providers
2013-03-19 05:04:30

Jason Pierce, MSN, MBA, RN for redOrbit.com — Your Universe Online A new study in the April edition of the Journal of Addiction Medicine suggests that propofol abuse by health care professionals is increasing. This appears to be especially true among physicians and nurses with easy access to the drug, such as those who provide anesthesia. The study also points out a number of characteristics common among health care professionals known to abuse propofol. The study´s authors, Dr...

2013-03-12 16:24:05

REDWOOD CITY, Calif., March 12, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the fourth quarter and year ended December 31, 2012, and provided a corporate update. (Logo: http://photos.prnewswire.com/prnh/20130226/MM67303LOGO) "We made important strides in the...

2013-02-28 16:29:07

CUPERTINO, Calif., Feb. 28, 2013 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended December 31, 2012. Total revenues were $3.3 million for the three months ended December 31, 2012 as compared to $8.9 million for the three months ended December 31, 2011. Net loss was $5.5 million for the three months ended December 31, 2012 as compared to a net loss of $2.1 million for the same period in 2011. (Logo:...

2013-02-22 08:23:41

CUPERTINO, Calif., Feb. 22, 2013 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2012 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, February 28, 2013 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage...